Mar 20
|
Zacks Investment Ideas feature highlights: Apple, Alphabet, Eli Lilly, Novo Nordisk and Viking Therapeutics
|
Mar 19
|
Time to be "Overweight" Viking Therapeutics
|
Mar 19
|
Warning: This Skyrocketing Stock Has a Hidden Risk
|
Mar 17
|
Where Will Viking Therapeutics Be in 5 Years?
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
Mar 16
|
Will Viking Therapeutics Get Acquired?
|
Mar 15
|
2 Stocks That Have More Than Tripled This Year: Are They Buys?
|
Mar 15
|
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
|
Mar 14
|
Ionis (IONS) Drug Meets Mid-Stage MASH Study Goals
|
Mar 14
|
12 Most Profitable Biotech Stocks To Invest In
|
Mar 13
|
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
|
Mar 13
|
Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March
|
Mar 13
|
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
|
Mar 11
|
Is Viking Therapeutics Stock a Buy?
|
Mar 9
|
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
|
Mar 8
|
3 Stock Winners That Are Up 1,000% or More in 2024
|
Mar 8
|
Novo Nordisk (NVO) Up on Upbeat Data From New Obesity Pill Study
|
Mar 8
|
Viking (VKTX) Stock Down on Novo Nordisk's Obesity Pill Data
|
Mar 7
|
Why Viking Therapeutics Stock Is Plunging Today
|
Mar 6
|
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
|